We distill cutting-edge medical technologies to their essence, then re-invent them as affordable, reliable, easy-to-use tools that work in places where resources are limited, power is scarce, or trained health care workers are few and far between.
At PATH, we connect local innovators and decision-makers with our global network of partners to develop responsive, human-centered solutions to health challenges.
Family planning advocates can ensure that a country’s policies and funding promote access to all contraceptive options, so women can make an informed and voluntary choice. The Advocacy Pack for Subcutaneous DMPA was designed for advocates around the globe to help increase access to this new injectable contraceptive option.
The DMPA-SC Evidence to Practice workshop was held in May 2018 with the goal of increasing voluntary and high-quality access to DMPA-SC within a wide range of contraceptive methods.
Women want and need access to a variety of contraceptive a variety of contraceptives to plan, space, and prevent pregnancies over the course of their lives. DMPA-SC (brand name Sayana® Press) is an all-in-one contraceptive that puts women in charge of their reproductive health.
Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.